9 months ago
IRTC
AnalystsDavid RescottDavid Rescott's Stock Forecasts
AnalystsDavid Rescott
Sectors:
Analyst Ranking
Bottom 26%
#3509 out of 4676 analysts
Average Return
-0.13%
Win Rate
41%17 out of 41
Risk vs Reward
Poor
Good
David Rescott's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Penumbra IncPEN | +141.93% | $124.98 | $302.36 | 2022-07-20 - 2023-07-19 | Strong Buy |
Si Bone IncSIBN | +65.40% | $12.08 | $19.98 | 2022-12-20 - 2023-12-19 | Strong Buy |
Boston Scientific CorpBSX | +52.90% | $53.97 | $82.52 | 2023-09-21 - 2024-09-17 | Buy |
Penumbra IncPEN | +45.36% | $199.65 | $290.22 | 2022-09-13 - 2023-09-12 | Strong Buy |
Boston Scientific CorpBSX | +44.34% | $52.34 | $75.55 | 2023-07-19 - 2024-07-18 | Buy |
David Rescott Analyst Color
Get additional color on David Rescott's coverage of popular stocks
9 months ago
SIBN
9 months ago
PEN
9 months ago
AXNX
9 months ago
IRTC
a year ago
PEN
a year ago
IRTC
David Rescott's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Livanova PLCLIVN | 1 | Buy | $66.00 | +29.41% | Upgrades | a day ago |
Medtronic PLCMDT | 2 | Hold | $90.00 | +1.55% | Maintains | a month ago |
Penumbra IncPEN | 14 | Buy | $180.00 | -3.77% | Maintains | 2 months ago |
Inari Medical IncNARI | 2 | Buy | $63.00 | +42.86% | Maintains | 2 months ago |
Boston Scientific CorpBSX | 4 | Buy | $91.00 | +10.28% | Maintains | 2 months ago |
Edwards Lifesciences CorpEW | 2 | Hold | $70.00 | +4.12% | Downgrades | 2 months ago |
Irhythm Technologies IncIRTC | 7 | Strong Buy | $134.00 | +87.39% | Maintains | 2 months ago |
Merit Medical Systems IncMMSI | 1 | Buy | $96.00 | -2.55% | Initiates Coverage On | 3 months ago |
Axonics IncAXNX | 8 | Hold | $71.00 | +3.05% | Downgrades | 8 months ago |
Si Bone IncSIBN | 5 | Strong Buy | $26.00 | +65.82% | Maintains | 9 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.